D-Allo-Thr(8)-Lanreotide

SL-12102

D-Allo-Thr(8)-Lanreotide, >95%

Synonyms : D-Allo-Thyronine-Liraglutide

IUPAC Name : D-2-Naphthylalanyl-L-cystyl-L-tyrosyl-D-trytophyl-L-lysyl-L-valyl-L-cystyl-D-Allo-threoninamide (disulfide bridge between Cys2-Cys7)

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an impurity of Lanreotide, which is a Somatostatin analog with antineoplastic activity. Lanreotide can be used for the research of carcinoid syndrome.

References : Ning S. et al.: Endocr Relat Cancer., 16(3), 1045-55, 2009; Florio T. et al.: Clin Endocrinol (Oxf), 59(1), 115-28., 2003.

Storage : Keep container tightly closed under nitrogen or argon and store at -20^oC for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.